Laura Marie Deedigan

Laura Marie Deedigan has a diverse background in the fields of research, development, and analytical testing. Their work experience began in 2005 at the Marine Institute, where they worked as a Biotoxin Chemistry Group Bursar Student. In this role, they contributed to monitoring and analytical services related to marine biotoxins.

In 2006, Laura joined Stryker as an R&D Product Development Student and later took on a GMP manufacturing work placement. During their time at Stryker, they gained experience in clean room manufacturing, quality control, and project management.

Laura then pursued their Ph.D. at the National University of Ireland, Galway, from 2007 to 2012. Their research focused on the molecular mechanisms of 5-fluorouracil-induced apoptosis in colorectal cancer cells and the use of 5-FU as a sensitizing agent to TRAIL.

Following their Ph.D., Laura joined Orbsen Therapeutics Limited in 2012. Laura Marie initially worked as a Senior R&D Staff Scientist, where they contributed to the identification of factors that modulate the immunoprivileged state of mesenchymal stromal cells. Laura Marie continued their work at Orbsen as a Product Development R&D Team Lead, leading a team of junior scientists in the development of a novel therapy using stromal cell-derived exosomes.

In 2016, Laura took on the role of Head of Analytical Development, Cell & Gene Therapy at Orbsen Therapeutics. In this position, they report directly to the C.S.O. and oversees the daily operations of the analytical development team.

Overall, Laura Marie Deedigan has extensive experience in research, product development, and analytical testing within the pharmaceutical and biotechnology industries.

Laura Marie Deedigan completed their education history as follows:

From 1998 to 2003, they attended St. Nessan's Community College, where they obtained a Leaving Certificate. Their field of study included higher level subjects such as English, Biology, Phys/Chem, French, and Art.

Subsequently, they enrolled at the University of Limerick from 2003 to 2007 and achieved a Bachelor of Science (B.Sc.) in Industrial Biochemistry (Hons).

From 2007 to 2012, Laura pursued their Doctor of Philosophy (Ph.D.) at the University of Galway. Their research focus during this time was the molecular biology of colorectal cancer.